"In 2012, Biota merged with Maryland-based Nabi Pharmaceuticals saying that it was primarily for the BARDA contract and to access $US54 million in cash, eventually settling for $US27 million in cash (BD: Apr 23, Sep 18, Oct 30, 2012).
Biota later moved about 500 miles to Georgia despite claiming the proximity to the US Food and Drug Administration as one of the reasons for the merger (BD: Apr 17, 2013)"
This article was very interesting in some of the points it made, such as the above, leading the reader to draw their own conclusions...
Add to My Watchlist
What is My Watchlist?